Stock futures slip after Trump tariff uncertainty. Watch Merck’s restructuring, Domino’s Q4 surge, Gilead’s Arcellx deal, and ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Merck (MRK) announced plans to separate its core pharmaceutical division into two units as it prepares for the upcoming patent expiration of its top-selling drug. The drugmaker said it is organizing ...

Merck & Co. Inc. (NYSE:MRK) is one of the best value stocks to buy now. On February 19, Merck announced positive second-season findings from the Phase 3 SMART trial evaluating ENFLONSIA (clesrovimab) ...

Merck & Co. (MRK) shares clocked seven straight sessions of gains, as the stock was up 0.2% at $124.1 on Tuesday. The global ...

As a constituent of leading indices including the Dow Jones Industrials Average Merck & Co., Inc. (NYSE:MRK) maintains visibility among large-cap healthcare peers. Index inclusion underscores its ...

Merck & Co., Inc. (NYSE:MRK) is included among the 14 Best Low Volatility Dividend Stocks to Invest in. On February 20, Barclays started coverage of Merck & Co., Inc. (NYSE:MRK) with an Overweight ...

Impax Asset Management‘s “Impax US Sustainable Economy Fund” released its Q4 2025 investor letter. A copy of the letter can ...

Merck reaches new high after earnings update, oncology restructuring, and clinical progress, highlighting position within the Russell 1000 large capitalization healthcare landscape.

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the September 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...

Merck (MRK)’s stock surged by 41% in the last six months, driven not only by a modest revenue increase but also by a significant profit jump and heightened investor confidence. The factors behind this ...